ADROMEDA AS: årsregnskap 2023 vs 2022
Grew 86% on revenue, returned to profit
approved 2024-06-18; registry 2024-06-20; journal 2024 525452
Summary
What changed
Comparing Årsregnskap 2023 with 2022 for ADROMEDA AS. Revenue 2 703 NOK → 5 015 NOK (+85.5%). Net result -702.5k NOK → +918.0k NOK. Equity -7.81m NOK → -6.90m NOK.
On the constructive side: revenue rose; operating result improved; turned profitable. Pressures included: cash fell.
Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for ADROMEDA AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 2 703 NOK to 5 015 NOK (+85.5% YoY). Calculated
-
↑
Operating result improved
Operating result -22.6k NOK → -21.2k NOK (op. margin -834.3% → -422.2%). Calculated
-
↑
Turned profitable
Net result flipped from a loss of 702.5k NOK to a profit of 918.0k NOK. Calculated
-
↑
Equity strengthened
Book equity -7.81m NOK → -6.90m NOK (equity ratio -1654.9% → -1744.9%). Calculated
What deteriorated
-
↓
Cash fell
Bank deposits 290.5k NOK → 213.5k NOK (-26.5% YoY). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -1744.9% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation